drugset / Trial / NCT00424892
Study Evaluating DVS SR in Patients With Fibromyalgia Syndrome
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary objective is to evaluate the long-term safety of desvenlafaxine succinate sustained-release (DVS SR) during open-label treatment in adult outpatients with fibromyalgia syndrome.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | — | — |